+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Computational Biology Market - Global Forecast 2026-2032- Product Image
Computational Biology Market - Global Forecast 2026-2032- Product Image
Sale

Computational Biology Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4896509
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Computational Biology Market is projected to reach USD 10.50 Billion in 2026. It is expected to continue growing at a CAGR of 19.52%, reaching USD 30.78 Billion by 2032.

Computational biology has moved from a specialist research discipline to a strategic engine for genomics, drug discovery, precision medicine, agricultural biotechnology, and public health surveillance. The field combines bioinformatics, systems biology, molecular modeling, machine learning, high-performance computing, and multi-omics analytics to interpret biological data at scale.

Industry adoption is being accelerated by validated public assets such as the Protein Data Bank, NCBI resources, EMBL-EBI databases, UK Biobank, the NIH All of Us Research Program, and the AlphaFold Protein Structure Database, which has made more than 200 million predicted protein structures available to researchers. These data foundations are reshaping how organizations identify disease mechanisms, prioritize therapeutic targets, and design evidence-based biological products.

Transformative Shifts in the Computational Biology Landscape

The computational biology landscape is being transformed by the convergence of population-scale sequencing, cloud-native bioinformatics, automated laboratories, and interoperable health data. Declining sequencing costs, broader access to next-generation sequencing, and growth in single-cell and spatial omics are expanding the volume and complexity of biological datasets.

At the same time, research organizations are shifting from isolated analysis pipelines to integrated platforms that connect genomics, transcriptomics, proteomics, metabolomics, imaging, clinical phenotypes, and real-world evidence. This shift favors providers that can deliver reproducible workflows, secure data governance, scalable compute, and domain-specific analytics for regulated life science environments.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is having a cumulative impact across computational biology by improving pattern recognition, protein structure prediction, target discovery, biomarker identification, and clinical trial stratification. Deep learning models now help analyze high-dimensional omics data, predict molecular interactions, support de novo protein design, and reduce the search space in early-stage drug discovery.

The value of AI depends on validated datasets, transparent model performance, bias monitoring, and biological confirmation. Industry leaders are therefore combining foundation models, graph neural networks, molecular simulations, and wet-lab validation rather than treating AI outputs as standalone evidence. This integration is strengthening decision quality while raising demand for explainable AI, data lineage, and regulatory-grade documentation.

Key Regional Insights

Asia-Pacific is becoming a high-growth center for computational biology as China, India, Japan, South Korea, Australia, and Singapore expand genomics programs, AI research capacity, and biomanufacturing infrastructure. North America remains the deepest innovation base, supported by NIH-funded research, large biobanks, advanced cloud platforms, FDA engagement with real-world evidence, and a dense biotechnology ecosystem. Europe continues to lead in cross-border research coordination through EMBL-EBI, ELIXIR, Horizon Europe, national genome programs, and strict data protection frameworks.

Latin America is gaining momentum through infectious disease genomics, biodiversity research, cancer studies, and academic bioinformatics networks, with Brazil and Mexico playing important roles. The Middle East is investing in precision medicine and national genome initiatives, particularly in the Gulf, while Africa is building capacity through pathogen surveillance, human genetics research, and collaborative networks such as H3Africa and regional sequencing centers. Together, these regions show that computational biology adoption is increasingly global, but infrastructure, workforce depth, and data governance maturity vary significantly.

Key Group Insights

ASEAN countries are expanding computational biology through biomedical research hubs, digital health programs, and regional infectious disease surveillance, with Singapore acting as a major genomics and AI anchor. The GCC is advancing population genomics and precision health through national strategies, hospital modernization, and sovereign cloud investments. The European Union is strengthening data-sharing frameworks through the European Health Data Space, the 1+ Million Genomes initiative, ELIXIR, and research funding that supports FAIR data principles.

BRICS economies are important because they combine large populations, biodiversity, sequencing demand, and growing domestic bioinformatics capabilities. The G7 continues to dominate advanced computational biology through research funding, pharmaceutical R&D, supercomputing, and regulatory science. NATO countries add relevance through biosecurity, pathogen surveillance, and dual-use risk governance, making trusted computational biology infrastructure an increasingly important component of national resilience.

Key Country Insights

The United States leads in computational biology due to NIH funding, top-tier academic centers, large-scale programs such as All of Us, and a strong AI-drug discovery ecosystem. Canada benefits from genomics networks, public health data science, and cancer research collaborations, while Mexico and Brazil are strengthening regional capacity through university-led bioinformatics, pathogen sequencing, and biodiversity-linked genomics. In Europe, the United Kingdom stands out through Genomics England and the NHS Genomic Medicine Service, while Germany, France, Italy, and Spain combine strong academic research, pharmaceutical capabilities, and EU-funded data infrastructure; Russia retains scientific expertise but faces constraints related to international collaboration and advanced computing access.

China is a major force in sequencing, AI research, and biomanufacturing, supported by large institutions and extensive genomic infrastructure. India is scaling genomics through initiatives such as GenomeIndia, digital public infrastructure, and a large biotechnology talent pool. Japan combines AMED-backed biomedical research, supercomputing strength, and aging-population health priorities, while Australia has built a strong precision medicine and population genomics profile. South Korea is advancing bioinformatics, digital hospitals, and AI-enabled drug discovery through coordinated national biotechnology strategies.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize interoperable computational biology platforms that connect multi-omics, clinical, imaging, and real-world data while maintaining strong privacy, cybersecurity, and auditability. Investment in standardized workflows, containerized pipelines, metadata quality, and FAIR data practices can improve reproducibility and reduce the friction that slows translation from discovery to clinical or commercial application.

Executives should also build AI governance models that require biological validation, model monitoring, and clear accountability. Strategic partnerships with academic centers, sequencing laboratories, hospitals, and regulatory experts can accelerate innovation while reducing execution risk. Workforce development in bioinformatics, machine learning, statistics, and molecular biology should be treated as a core growth requirement rather than a support function.

Research Methodology

This executive summary is based on a structured research methodology that combines secondary research, expert interpretation, and cross-validation of public evidence. Sources considered include peer-reviewed literature, public research databases, clinical trial registries, government funding programs, regulatory guidance, patent activity, scientific infrastructure initiatives, and internationally recognized genomics and bioinformatics resources.

Insights were assessed for relevance to computational biology adoption, AI integration, regional competitiveness, and enterprise strategy. Findings were triangulated across data availability, institutional capacity, technology readiness, regulatory context, and demonstrated use cases in genomics, drug discovery, precision medicine, public health, and biotechnology innovation.

Conclusion

Computational biology is becoming a core capability for organizations seeking faster discovery, better biological understanding, and more precise decision-making. The combination of AI, multi-omics, cloud computing, and validated biological databases is enabling new approaches to target identification, therapeutic development, diagnostics, and health system innovation.

The next phase of competition will be defined by trustworthy data ecosystems, explainable models, reproducible workflows, and the ability to translate computational insight into experimentally validated outcomes. Organizations that align scientific rigor with scalable digital infrastructure will be best positioned to capture long-term value in computational biology.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Computational Biology Market, by Product Type
7.1. Introduction
7.2. Instruments
7.2.1. Imaging Systems
7.2.2. Mass Spectrometry Instruments
7.2.3. Microarray Scanners
7.2.4. PCR Instruments
7.2.5. Sequencing Instruments
7.3. Reagents & Consumables
7.4. Software & Services
7.4.1. Bioinformatics Services
7.4.2. Data Analysis Software
7.4.3. Instrument Maintenance Services
8. Computational Biology Market, by Technology
8.1. Introduction
8.2. Imaging Systems
8.2.1. Confocal Microscopy
8.2.2. Electron Microscopy
8.2.3. Fluorescence Imaging
8.3. Microarray
8.3.1. DNA Microarray
8.3.2. Protein Microarray
8.4. Mass Spectrometry
8.5. Next Gen Sequencing
8.5.1. Illumina Sequencing
8.5.2. Ion Torrent Sequencing
9. Computational Biology Market, by Application
9.1. Introduction
9.2. Diagnostics
9.2.1. Cancer Diagnostics
9.2.2. Genetic Testing
9.2.3. Infectious Disease
9.3. Drug Discovery
9.3.1. Lead Optimization
9.3.2. Target Identification
9.3.3. Toxicity Screening
9.4. Genomic Analysis
9.4.1. DNA Sequencing
9.4.2. Epigenetic Analysis
9.4.3. RNA Sequencing
9.5. Proteomic Analysis
9.5.1. Protein Identification
9.5.2. PTM Analysis
9.5.3. Quantitative Proteomics
10. Computational Biology Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.2.1. Government Research Centers
10.2.2. Universities
10.3. Contract Research Organizations
10.3.1. Large CROs
10.3.2. Niche CROs
10.4. Hospitals & Diagnostic Laboratories
10.4.1. Hospital Laboratories
10.4.2. Independent Diagnostic Laboratories
10.5. Pharmaceutical & Biotechnology Companies
10.5.1. Biotechnology Companies
10.5.2. Pharmaceutical Companies
11. Computational Biology Market, by Distribution Channel
11.1. Introduction
11.2. Online
11.3. Offline
12. Computational Biology Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Computational Biology Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Computational Biology Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. 10x Genomics, Inc.
16.2. Agilent Technologies, Inc.
16.3. BGI Group
16.4. Bio-Rad Laboratories, Inc.
16.5. BioDiscovery Group
16.6. biomodal Limited
16.7. DNASTAR, Inc.
16.8. Eurofins Genomics LLC
16.9. F. Hoffmann-La Roche Ltd
16.10. Genevia Technologies Oy
16.11. Genomics Ltd.
16.12. HaploX
16.13. Illumina, Inc.
16.14. Integrated DNA Technologies, Inc.
16.15. Labcorp Genetics Inc.
16.16. Labvantage - Biomax GmbH
16.17. Novo Nordisk A/S
16.18. Oxford Nanopore Technologies plc.
16.19. Pacific Biosciences of California, Inc.
16.20. Partek Incorporated
16.21. PerkinElmer, Inc.
16.22. Qiagen N.V.
16.23. RIKEN GENESIS CO.,LTD.
16.24. SOPHiA GENETICS SA
16.25. Telesis Bio Inc.
16.26. Thermo Fisher Scientific Inc.
16.27. Veracyte, Inc.
16.28. Waters Corporation
List of Figures
FIGURE 1. GLOBAL COMPUTATIONAL BIOLOGY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL COMPUTATIONAL BIOLOGY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL COMPUTATIONAL BIOLOGY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL COMPUTATIONAL BIOLOGY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 15. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL COMPUTATIONAL BIOLOGY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL COMPUTATIONAL BIOLOGY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL COMPUTATIONAL BIOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL MASS SPECTROMETRY INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL MASS SPECTROMETRY INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL MASS SPECTROMETRY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL MICROARRAY SCANNERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL MICROARRAY SCANNERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL MICROARRAY SCANNERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL PCR INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL PCR INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL PCR INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL SEQUENCING INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL SEQUENCING INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL SEQUENCING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL BIOINFORMATICS SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL BIOINFORMATICS SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL BIOINFORMATICS SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL DATA ANALYSIS SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL DATA ANALYSIS SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL DATA ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL INSTRUMENT MAINTENANCE SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL INSTRUMENT MAINTENANCE SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL INSTRUMENT MAINTENANCE SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL CONFOCAL MICROSCOPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL CONFOCAL MICROSCOPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CONFOCAL MICROSCOPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL ELECTRON MICROSCOPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL ELECTRON MICROSCOPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL ELECTRON MICROSCOPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL FLUORESCENCE IMAGING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL FLUORESCENCE IMAGING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL FLUORESCENCE IMAGING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL MICROARRAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL MICROARRAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL MICROARRAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL DNA MICROARRAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL DNA MICROARRAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL DNA MICROARRAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL PROTEIN MICROARRAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL PROTEIN MICROARRAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL PROTEIN MICROARRAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL NEXT GEN SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL NEXT GEN SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL NEXT GEN SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL ILLUMINA SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL ILLUMINA SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL ILLUMINA SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL ION TORRENT SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL ION TORRENT SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL ION TORRENT SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL DRUG DISCOVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL LEAD OPTIMIZATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL LEAD OPTIMIZATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL LEAD OPTIMIZATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL TARGET IDENTIFICATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL TARGET IDENTIFICATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL TARGET IDENTIFICATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL TOXICITY SCREENING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL TOXICITY SCREENING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL TOXICITY SCREENING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL GENOMIC ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL GENOMIC ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL GENOMIC ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL DNA SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL DNA SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL DNA SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL EPIGENETIC ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL EPIGENETIC ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL EPIGENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL RNA SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL RNA SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL RNA SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL PROTEOMIC ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL PROTEOMIC ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL PROTEOMIC ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL PROTEIN IDENTIFICATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL PROTEIN IDENTIFICATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL PROTEIN IDENTIFICATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL PTM ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL PTM ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL PTM ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL QUANTITATIVE PROTEOMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL QUANTITATIVE PROTEOMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL QUANTITATIVE PROTEOMICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL GOVERNMENT RESEARCH CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL GOVERNMENT RESEARCH CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL GOVERNMENT RESEARCH CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL UNIVERSITIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL UNIVERSITIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL UNIVERSITIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL LARGE CROS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL LARGE CROS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL LARGE CROS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL NICHE CROS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL NICHE CROS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL NICHE CROS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL HOSPITALS & DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL HOSPITALS & DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL HOSPITALS & DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL HOSPITAL LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL HOSPITAL LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL HOSPITAL LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL INDEPENDENT DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL INDEPENDENT DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL INDEPENDENT DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 154. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 155. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 157. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 158. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 159. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 160. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 161. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 162. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 163. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 164. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY, 2017-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY NEXT GEN SEQUENCING, 2017-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY GENOMIC ANALYSIS, 2017-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEOMIC ANALYSIS, 2017-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2017-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2017-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 184. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 185. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 186. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 187. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 188. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 189. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 190. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY, 2017-2032 (USD MILLION)
TABLE 191. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY NEXT GEN SEQUENCING, 2017-2032 (USD MILLION)
TABLE 192. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 193. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 194. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 195. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY GENOMIC ANALYSIS, 2017-2032 (USD MILLION)
TABLE 196. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEOMIC ANALYSIS, 2017-2032 (USD MILLION)
TABLE 197. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 198. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 199. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2017-2032 (USD MILLION)
TABLE 200. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 201. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2017-2032 (USD MILLION)
TABLE 202. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 203. LATIN AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 204. LATIN AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 205. LATIN AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 206. LATIN AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 207. LATIN AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 208. LATIN AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 209. LATIN AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY, 2017-2032 (USD MILLION)
TABLE 210. LATIN AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY NEXT GEN SEQUENCING, 2017-2032 (USD MILLION)
TABLE 211. LATIN AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 212. LATIN AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 213. LATIN AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 214. LATIN AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY GENOMIC ANALYSIS, 2017-2032 (USD MILLION)
TABLE 215. LATIN AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEOMIC ANALYSIS, 2017-2032 (USD MILLION)
TABLE 216. LATIN AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 217. LATIN AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 218. LATIN AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2017-2032 (USD MILLION)
TABLE 219. LATIN AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 220. LATIN AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2017-2032 (USD MILLION)
TABLE 221. LATIN AMERICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 222. EUROPE COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 223. EUROPE COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 224. EUROPE COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 225. EUROPE COMPUTATIONAL BIOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 226. EUROPE COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 227. EUROPE COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 228. EUROPE COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY, 2017-2032 (USD MILLION)
TABLE 229. EUROPE COMPUTATIONAL BIOLOGY MARKET SIZE, BY NEXT GEN SEQUENCING, 2017-2032 (USD MILLION)
TABLE 230. EUROPE COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 231. EUROPE COMPUTATIONAL BIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 232. EUROPE COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 233. EUROPE COMPUTATIONAL BIOLOGY MARKET SIZE, BY GENOMIC ANALYSIS, 2017-2032 (USD MILLION)
TABLE 234. EUROPE COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEOMIC ANALYSIS, 2017-2032 (USD MILLION)
TABLE 235. EUROPE COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 236. EUROPE COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 237. EUROPE COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2017-2032 (USD MILLION)
TABLE 238. EUROPE COMPUTATIONAL BIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 239. EUROPE COMPUTATIONAL BIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2017-2032 (USD MILLION)
TABLE 240. EUROPE COMPUTATIONAL BIOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 241. MIDDLE EAST COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 242. MIDDLE EAST COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 243. MIDDLE EAST COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 244. MIDDLE EAST COMPUTATIONAL BIOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 245. MIDDLE EAST COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 246. MIDDLE EAST COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 247. MIDDLE EAST COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY, 2017-2032 (USD MILLION)
TABLE 248. MIDDLE EAST COMPUTATIONAL BIOLOGY MARKET SIZE, BY NEXT GEN SEQUENCING, 2017-2032 (USD MILLION)
TABLE 249. MIDDLE EAST COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 250. MIDDLE EAST COMPUTATIONAL BIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 251. MIDDLE EAST COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 252. MIDDLE EAST COMPUTATIONAL BIOLOGY MARKET SIZE, BY GENOMIC ANALYSIS, 2017-2032 (USD MILLION)
TABLE 253. MIDDLE EAST COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEOMIC ANALYSIS, 2017-2032 (USD MILLION)
TABLE 254. MIDDLE EAST COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 255. MIDDLE EAST COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 256. MIDDLE EAST COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2017-2032 (USD MILLION)
TABLE 257. MIDDLE EAST COMPUTATIONAL BIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 258. MIDDLE EAST COMPUTATIONAL BIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2017-2032 (USD MILLION)
TABLE 259. MIDDLE EAST COMPUTATIONAL BIOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 260. AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 261. AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 262. AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 263. AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 264. AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 265. AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 266. AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY, 2017-2032 (USD MILLION)
TABLE 267. AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY NEXT GEN SEQUENCING, 2017-2032 (USD MILLION)
TABLE 268. AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 269. AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 270. AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 271. AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY GENOMIC ANALYSIS, 2017-2032 (USD MILLION)
TABLE 272. AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEOMIC ANALYSIS, 2017-2032 (USD MILLION)
TABLE 273. AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 274. AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 275. AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2017-2032 (USD MILLION)
TABLE 276. AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 277. AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2017-2032 (USD MILLION)
TABLE 278. AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 279. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 280. ASEAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 281. ASEAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 282. ASEAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 283. ASEAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 284. ASEAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 285. ASEAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 286. ASEAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY, 2017-2032 (USD MILLION)
TABLE 287. ASEAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY NEXT GEN SEQUENCING, 2017-2032 (USD MILLION)
TABLE 288. ASEAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 289. ASEAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 290. ASEAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 291. ASEAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY GENOMIC ANALYSIS, 2017-2032 (USD MILLION)
TABLE 292. ASEAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEOMIC ANALYSIS, 2017-2032 (USD MILLION)
TABLE 293. ASEAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 294. ASEAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 295. ASEAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2017-2032 (USD MILLION)
TABLE 296. ASEAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 297. ASEAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2017-2032 (USD MILLION)
TABLE 298. ASEAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 299. GCC COMPUTATIONAL BIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 300. GCC COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 301. GCC COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 302. GCC COMPUTATIONAL BIOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 303. GCC COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 304. GCC COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 305. GCC COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY, 2017-2032 (USD MILLION)
TABLE 306. GCC COMPUTATIONAL BIOLOGY MARKET SIZE, BY NEXT GEN SEQUENCING, 2017-2032 (USD MILLION)
TABLE 307. GCC COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 308. GCC COMPUTATIONAL BIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 309. GCC COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 310. GCC COMPUTATIONAL BIOLOGY MARKET SIZE, BY GENOMIC ANALYSIS, 2017-2032 (USD MILLION)
TABLE 311. GCC COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEOMIC ANALYSIS, 2017-2032 (USD MILLION)
TABLE 312. GCC COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 313. GCC COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 314. GCC COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2017-2032 (USD MILLION)
TABLE 315. GCC COMPUTATIONAL BIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 316. GCC COMPUTATIONAL BIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2017-2032 (USD MILLION)
TABLE 317. GCC COMPUTATIONAL BIOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 318. EUROPEAN UNION COMPUTATIONAL BIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 319. EUROPEAN UNION COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 320. EUROPEAN UNION COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 321. EUROPEAN UNION COMPUTATIONAL BIOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 322. EUROPEAN UNION COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 323. EUROPEAN UNION COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 324. EUROPEAN UNION COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY, 2017-2032 (USD MILLION)
TABLE 325. EUROPEAN UNION COMPUTATIONAL BIOLOGY MARKET SIZE, BY NEXT GEN SEQUENCING, 2017-2032 (USD MILLION)
TABLE 326. EUROPEAN UNION COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 327. EUROPEAN UNION COMPUTATIONAL BIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 328. EUROPEAN UNION COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 329. EUROPEAN UNION COMPUTATIONAL BIOLOGY MARKET SIZE, BY GENOMIC ANALYSIS, 2017-2032 (USD MILLION)
TABLE 330. EUROPEAN UNION COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEOMIC ANALYSIS, 2017-2032 (USD MILLION)
TABLE 331. EUROPEAN UNION COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 332. EUROPEAN UNION COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 333. EUROPEAN UNION COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2017-2032 (USD MILLION)
TABLE 334. EUROPEAN UNION COMPUTATIONAL BIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 335. EUROPEAN UNION COMPUTATIONAL BIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2017-2032 (USD MILLION)
TABLE 336. EUROPEAN UNION COMPUTATIONAL BIOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 337. BRICS COMPUTATIONAL BIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 338. BRICS COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 339. BRICS COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 340. BRICS COMPUTATIONAL BIOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 341. BRICS COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 342. BRICS COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 343. BRICS COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY, 2017-2032 (USD MILLION)
TABLE 344. BRICS COMPUTATIONAL BIOLOGY MARKET SIZE, BY NEXT GEN SEQUENCING, 2017-2032 (USD MILLION)
TABLE 345. BRICS COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 346. BRICS COMPUTATIONAL BIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 347. BRICS COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TA

Companies Mentioned

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • BioDiscovery Group
  • biomodal Limited
  • DNASTAR, Inc.
  • Eurofins Genomics LLC
  • F. Hoffmann-La Roche Ltd
  • Genevia Technologies Oy
  • Genomics Ltd.
  • HaploX
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Labcorp Genetics Inc.
  • Labvantage - Biomax GmbH
  • Novo Nordisk A/S
  • Oxford Nanopore Technologies plc.
  • Pacific Biosciences of California, Inc.
  • Partek Incorporated
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • RIKEN GENESIS CO.,LTD.
  • SOPHiA GENETICS SA
  • Telesis Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Veracyte, Inc.
  • Waters Corporation

Table Information

Report AttributeDetails
No. of Pages194
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 10.5 Billion
Forecasted Market Value ( USD ) by 2032 $ 30.78 Billion
Compound Annual Growth Rate19.5%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Spatial Genomics & Transcriptomics Market - Global Forecast 2026-2032 - Product Image

Spatial Genomics & Transcriptomics Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Bioinformatics Services Market - Global Forecast 2026-2032 - Product Image

Bioinformatics Services Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Computational Biology - Global Strategic Business Report - Product Image

Computational Biology - Global Strategic Business Report

  • Report
  • 147 Pages
  • Global
From
Computational Biology Market Report by Application, Services, End Use, and Region 2026-2034 - Product Image

Computational Biology Market Report by Application, Services, End Use, and Region 2026-2034

  • Report
  • 138 Pages
  • Global
From
Structural Biology and Molecular Modeling Techniques - Global Strategic Business Report - Product Image

Structural Biology and Molecular Modeling Techniques - Global Strategic Business Report

  • Report
  • 167 Pages
  • Global
From

About the Computational Biology Market

Computational Biology is a field of study that combines the principles of computer science and biology to analyze and interpret biological data. It is closely related to bioinformatics, which is the application of computer and information technology to the management of biological data. Computational Biology is used to study the structure and function of biological systems, such as proteins, DNA, and cells. It is also used to develop new methods for analyzing and interpreting biological data. The Computational Biology market is growing rapidly, driven by the increasing demand for data-driven solutions in the life sciences. This market is expected to continue to grow as more organizations adopt computational biology techniques to gain insights into biological systems. Some companies in the Computational Biology market include Illumina, Thermo Fisher Scientific, BGI, and Qiagen. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.